Meng, Xianmin
Lin, Xiaoyan
Jiang, Rongrong
Lu, Yan
Zeng, Liyan
Cao, Ming
Zhang, Jianliang
Clinical trials referenced in this document:
Documents that mention this clinical trial
Effect of Food on the Pharmacokinetics of Senaparib (IMP4297) in Healthy Chinese Subjects
https://doi.org/10.1007/s40261-022-01198-8
Funding for this research was provided by:
IMPACT Therapeutics
Article History
Accepted: 29 August 2022
First Online: 14 October 2022
Declarations
:
: This study was sponsored by IMPACT Therapeutics and the sponsor was involved in the study design, analysis, and interpretation of the data.
: Xianmin Meng, Xiaoyan Lin, Rongrong Jiang, Yan Lu, Liyan Zeng, Ming Cao, and Jianliang Zhang have no conflicts of interest that are directly relevant to the content of this article.
: The informed consent form and other information available for subjects have been reviewed by the Medical Ethics Committee of Shanghai Public Health Clinical Center. All the modifications of the protocol had been approved by the ethics committee. The design, conduct, and reporting of the study adhered to Good Clinical Practice, Declaration of Helsinki, and current National Medical Products Administration regulations.
: Informed consent was obtained from all the subjects prior to study enrollment.
: Not applicable.
: The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
: Not applicable.
: XM wrote the manuscript. All authors took part in the collection of data and contributed to the review of the manuscript.